Individualized treatment based on CYP3A5 single-nucleotide polymorphisms with tacrolimus in ulcerative colitis

BACKGROUND/AIMS: The pharmacokinetics of tacrolimus (TAC) is known to be largely influenced by single-nucleotide polymorphisms (SNPs) in CYP3A5. Patients starting TAC require careful dose adjustment, owing to the wide range of optimal dosages, depending on their CYP3A5 expression status. Here, we ev...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Intest Res
Κύριοι συγγραφείς: Okabayashi, Shinji, Kobayashi, Taku, Saito, Eiko, Toyonaga, Takahiko, Ozaki, Ryo, Sagami, Shintaro, Nakano, Masaru, Tanaka, Junichi, Yagisawa, Keiji, Kuronuma, Satoshi, Takeuchi, Osamu, Hibi, Toshifumi
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Korean Association for the Study of Intestinal Diseases 2019
Θέματα:
Original Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6505090/
https://ncbi.nlm.nih.gov/pubmed/30704156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2018.00117
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια